Tissue Engineering-based Regeneration Products Market, Distribution by Type of Graft (Allografts, Autografts and Xenografts), Area of Application (Bone Healing, Burn Healing, Surgical Healing, Wound Healing, and Others), Type of Material of Scaffold (Bone Tissue, Collagen-based Tissue, Human Placental Tissue, Other Animal Based Tissue, Other Human Tissue, Stem Cell and Others Tissues), Type of End User (Ambulatory Surgical Centers / Hospitals / Specialty Clinics) And Key Geographies (North America, Europe, Asia, Latin America, Middle East and North Africa and Rest of the World): Industry Trends and Global Forecasts, 2022-2035

  • Lowest Price Guaranteed From USD 5,899

  • Published
    August 2022

  • Pages
    245

  • View Count
    932

Example Insights

Tissue-Engineering-based-Regeneration-Products-Market-Context-thumb Tissue-Engineering-based-Regeneration-Products-Market-List-of-Companies-thumb Tissue-Engineering-based-Regeneration-Products-Market-Developers-thumb Tissue-Engineering-based-Regeneration-Products-Market-Distribution-by-Product-Formulation-thumb
Tissue-Engineering-based-Regeneration-Products-Market-Company-Competitiveness-Analysis-thumb Tissue-Engineering-based-Regeneration-Products-Market-Partnerships-and-Collaborations-thumb Tissue-Engineering-based-Regeneration-Products-Market-Recent-Initiatives-thumb Tissue-Engineering-based-Regeneration-Products-Market-Grant-Analysis-thumb
Tissue-Engineering-based-Regeneration-Products-Market-Patent-Analysis-thumb Tissue-Engineering-based-Regeneration-Products-Market-Growth-Scenarios-thumb Tissue-Engineering-based-Regeneration-Products-Market-Opportunity-thumb  

Overview

From commercial point of view, allograft is the most reasonable option as, from safety point of view, the accommodation of the autologous cells in tissue engineering is a challenging process

-- Head, Cell and Tissue Culture Laboratory, a large-sized organization

Research indicates that about 6% of the individuals are expected to get affected from chronic wounds, globally. Specifically, in the US, 6.5 million individuals are estimated to be affected by chronic wounds. Financially, treatment of wound-related complications levies a burden of over USD 25 billion, annually, on the US healthcare system. In other words, treatment and care of chronic wounds is believed to account for more than 5% of the National Healthcare Service (NHS) expenditure in the aforementioned region. Traditionally, the treatment of chronic wounds involves transplantation of undamaged tissues and organs to replace injured and damaged parts of the body. As congenital abnormalities, injuries and diseases cause humans to lose tissues throughout their lives, there is a huge demand for donated tissues, which is further supported by the complete dependence on transplantation for treatment. At present, the supply of tissue donations is insufficient to satisfy the required demand. It is worth highlighting that, in recent years, tissue engineering and regenerative medicine have emerged as promising alternatives for tissue regeneration. The average treatment cost associated with tissue engineering is reported to be in range of USD 1,800 to USD 3,000, which serves as a more viable treatment option as compared to the conventional methods (the average cost of a skin transplant ranges from USD 18,000 to USD 28,000). As a result, replacing damaged skin with skin cell sheets has become a prominent and preferred treatment option for patients. 

At present, more than 160 tissue engineering products and regenerative medicine products have been / are being developed by several companies located across the globe. It is worth mentioning that these products have demonstrated the potential to enable regeneration of tissues (including the skin and bones), as well as the ability to cure some congenital abnormalities. Given the various benefits offered with such products, including better biocompatibility, faster tissue regeneration, easy availability and high affordability, the tissue engineering market has garnered the attention of various venture capital firms and strategic investors. In fact, industry players have raised about USD 2 billion in the recent past in order to drive research efforts aimed at exploring different types of tissue engineering-based regeneration products (primarily focused on bone healing, wound healing and burn healing). In addition, over 800 grants have been awarded by academic and government organizations in the tissue engineering industry. Driven by the continuous efforts of researchers and industry players, there has also been a considerable rise in the number of patents filed in this market. In recent years, through the use of novel technologies, certain complex and more sophisticated tissue reconstructions have also been successfully completed, indicating that more complex tissue engineering procedures may be possible in the near future. Considering the ongoing pace of innovation in this field, coupled to the recent shift in preference from traditional transplants procedure to tissue engineering-based regeneration products, we believe that the tissue engineering market is likely to witness significant growth in the foreseen future.

Scope of the Report

The “Tissue Engineering-based Regeneration Products Market, Distribution by Type of Graft (Allografts, Autografts and Xenografts), Area of Application (Bone Healing, Burn Healing,  Surgical Healing, Wound Healing, and Others), Type of Material of Scaffold (Bone Tissue, Collagen-based Tissue, Human Placental Tissue, Other Animal Based Tissue, Other Human Tissue,  Stem Cell and Others Tissues), Type of End User (Ambulatory Surgical Centers / Hospitals / Specialty Clinics) And Key Geographies (North America, Europe, Asia, Latin America, Middle East and North Africa and Rest of the World): Industry Trends and Global Forecasts, 2022-2035” report features an extensive study of the current market landscape and future potential of the tissue engineering-based regeneration products market. The study features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in providing the tissue engineering-based regeneration products. Amongst other elements, the report features:

  • A detailed review of the current market landscape of tissue engineering-based skin regeneration products based on several relevant parameters, such as type of graft (allografts / autografts / xenografts), area of application (burn healing / surgical healing / soft tissue skin regeneration / wound healing), type of material of scaffold (collagen-based tissues / human placental tissues / other human tissues / other animal-based tissues / other tissues) and launch year. In addition, the chapter lists the players providing tissue engineering-based skin regeneration products, along with information on their respective year of establishment, company size (very small / small / mid-sized / large / very large), location of headquarters (North America / Europe / Asia / Rest of the World) and target market (domestic only / both international and domestic).
  • A detailed review of the current market landscape of tissue engineering based-bone regeneration products based on several relevant parameters, such as type of graft (allografts / xenograft), formulation of product (bone matrix / bone putty / cortical fibers / powder / putty / sheet / sponge block), type of material of scaffold (bone tissue / collagen tissue / others / stem cell) and launch year. In addition, the chapter lists the players providing tissue engineering-based bone regeneration products, along with information on their respective year of establishment, company size (very small / small / mid-sized / large / very large), location of headquarters (North America / Europe / Asia / Rest of the World) and target market (domestic only / both international and domestic).
  • An in-depth analysis, highlighting the market trends through six different schematic representations, including [A] a world map representation, highlighting the regional distribution of the various tissue engineering based-regeneration products  providers, [B] a 4D bubble analysis comparing the key players engaged in this domain, based on several relevant parameters (such as year of establishment, company size, number of tissue engineering based-regeneration products offered and region), [C] an insightful spider web representation of tissue engineering based-regeneration products (based on type of graft and area of application), [D] a horizontal stacked bar chart representation presenting the distribution of tissue engineering based-regeneration products providers (based on area of application and material of scaffold), [E] a vertical stacked bar chart representation of tissue engineering-based regeneration products (distribution by product formulation and type of graft) and [F] a vertical stack  bar chart representation of tissue engineering based-regeneration products (distribution by region and type of market).
  • An insightful competitiveness analysis of players engaged in the development of tissue engineering-based regeneration products, based on several relevant parameters, such as years of experience, portfolio strength (in terms of area of applications,  material of scaffold, type of graft, number of products offered), partnerships activity (in terms of number of partnerships, year of partnerships, and type of partnerships), and funding activity (in terms of number of funding instances, amount of funding, year of funding, type of funding, and number of lead investors).
  • Elaborate profiles of prominent players that are currently engaged in offering tissue engineering-based regeneration products. Each profile features a brief overview of the company (including information on year of establishment, number of employees, location of headquarters and key executives). Additionally, the chapter includes company’s tissue regeneration product portfolio, details related to its recent developments and an informed future outlook.
  • An analysis of the various partnerships that have been inked between several stakeholders in the domain of tissue engineering-based regeneration products, during the period 2017-2022, covering various type of partnership such as mergers and acquisitions, distribution agreements, product development and commercialization agreements, product utilization agreements, R&D agreements and others, along with analysis on recent investments during the period 2018 and 2022 (till the time of analysis) including grant, debt, seed funding, venture series, IPO, private equity, private placement, other equity and others. Further, it includes analysis of other recent initiatives taken by various stakeholders engaged in this domain.
  • An insightful analysis on filed / granted patents focused on tissue engineering-based regeneration products, during the period 2000-2022 (till the month when the research / analysis was conducted). The analysis highlights key details and trends associated with these patents, including patent type (granted patents / patent application / search reports / limited patent), publication year, geographical location (North America / Europe / Asia-Pacific / World Intellectual Property Organization), assigned CPC symbol, emerging focus area, type of applicant (industry / non-industry) and leading industry / non-industry players (in terms of size of intellectual property portfolio). It also includes a patent benchmarking analysis and a detailed valuation analysis.
  • An analysis that provides information on more than 750 grants that were awarded to various research institutes engaged in studies related to tissue engineering-based regeneration products, during the period 2018 and 2022 (till the time of analysis). The analysis also highlights important parameters associated with grants, The analysis also highlights important parameters associated with grants, such as year of award, support period, amount awarded, funding institute, administration institute center, funding institute center, funding mechanism, spending categorization, grant type (research grants (r series) / research training and fellowships (t & f series) / program project/center grants (p series) / others), responsible study section, focus area, type of recipient organization (schools of medicine / biomedical engineering /college of engineering/ schools of arts and sciences / independent hospitals / domestic for-profits / other domestic non-profits / schools of dentistry/oral hygn / research institutes / domestic higher education / others) and prominent program officers. 

One of the key objectives of the report was to estimate the existing market size and identify potential growth opportunities for tissue engineering-based regeneration products market for the next 13 years. Additionally, it features market size projections for the tissue engineering-based regeneration products market, wherein both the current and upcoming opportunity is segmented across [A] type of graft (allografts / autografts / xenografts), [B] area of application (bone healing / burn healing / surgical healing / would healing / others), [C] type of material of scaffold (bone tissue, collagen-based tissue, human placental tissue, other animal-based tissue, other human tissue,  stem cell and others tissues) and [D] key geographies (North America, Europe, Asia, Latin America, Middle East and North Africa and rest of the world). In order to account for future uncertainties and to add robustness to our model, we have provided three market forecast scenarios, namely the conservative, base and optimistic scenarios, which represent different tracks of the industry’s evolution.

Key Questions Answered

  • Who are the leading players engaged in providing tissue engineering-based regeneration products?
  • Which tissue engineering-based regeneration products are most commonly offered by developers engaged in this market?
  • What is the relative competitiveness of tissue engineering-based regeneration product providers?
  • What types of partnership models are commonly being adopted by stakeholders in this industry? 
  • What is the trend for capital investments in the tissue engineering-based regeneration products market?
  • How has the patent landscape in this domain evolved over the last two decades?
  • What is the overall trend of grant activity related to tissue engineering-based regeneration products?
  • Which key market trends and driving factors are likely to impact the growth of the tissue engineering-based regeneration products market?
  • How is the current and future market opportunity likely to be distributed across key market segments?

Contents

Chapter Outlines

Chapter 2 is an executive summary of the insights captured during our research. The chapter offers a high-level view on the likely evolution of the tissue engineering-based regeneration products market in the short to mid-term and long term.

Chapter 3 provides a general introduction to tissue engineering, featuring information on various type of cell used in the process. Further, it provides a detailed discussion on its use in regenerative medicine. In addition, the chapter includes details related to various applications and challenges associated with tissue engineering-based regeneration products. The chapter concludes with a discussion on key growth drivers, as well as upcoming trends in this field.

Chapter 4 includes detailed assessment of the current market landscape of tissue engineering-based skin regeneration products based on several relevant parameters, such as such as type of graft (allografts  / autografts  / xenografts), area of application (burn healing / surgical healing / soft tissue skin regeneration / wound healing), type of material of scaffold (collagen-based tissues / human placental tissues / other human tissues / other animal-based tissues / other tissues) and launch year. In addition, the chapter lists the players providing tissue engineering-based skin regeneration products, along with information on their respective year of establishment, company size (very small / small / mid-sized / large / very large), location of headquarters (North America / Europe / Asia / Rest of the World) and target market (domestic only / both international and domestic).

Chapter 5 A detailed review of the current market landscape of tissue engineering based-bone regeneration products based on several relevant parameters, such as type of graft (allografts / xenografts), formulation of product (bone matrix / bone putty / cortical fibers / powder / putty / sheet / sponge block), type of material of scaffold (bone tissue / collagen tissue / others / stem cell) and launch year. In addition, the chapter lists the players providing tissue engineering-based skin regeneration products, along with information on their respective year of establishment, company size (very small / small / mid-sized / large / very large), location of headquarters (North America / Europe / Asia / Rest of the World) and target market (domestic only / both international and domestic).

Chapter 6 features an analysis, highlighting the market trends through six different schematic representations, including [A] a world map representation, highlighting the regional distribution of the various tissue engineering based-regeneration products  providers, [B] a 4D bubble analysis comparing the key players engaged in this domain, based on several relevant parameters (such as year of establishment, company size, number of tissue engineering based-regeneration products offered and region), [C] an insightful spider web representation of tissue engineering based-regeneration products (based on type of graft and area of application), [D] a horizontal stacked bar chart representation presenting the distribution of tissue engineering based-regeneration products providers (based on area of application and material of scaffold), [E] a vertical stacked bar chart representation of tissue engineering based-regeneration products (distribution by product formulation and type of graft) and [F] a vertical stack  bar chart representation of tissue engineering based-regeneration products (distribution by region and type of market).

Chapter 7 presents an  insightful competitiveness analysis of the players involved in the development of tissue engineering-based regeneration products, based on several relevant parameters, such as years of experience, portfolio strength (in terms of number of products offered, type of graft, area of applications, material of scaffold), partnerships activity (in terms of number of partnerships, year of partnerships, and type of partnerships), and funding activity (in terms of number of funding instances, amount of funding, year of funding, type of funding, and number of lead investors).

Chapter 8 Elaborate profiles of various prominent players that are currently engaged in offering tissue engineering-based regeneration products. Each profile features a brief overview of the company (including information on year of establishment, number of employees, location of headquarters and key executives), company’s tissue regeneration product portfolio, details related to its recent developments and an informed future outlook.

Chapter 9 An analysis of the partnerships that have been inked between various stakeholders in this domain, during the period 2017-2022, covering several type of partnership models such as mergers and acquisitions, distribution agreements, product development and commercialization agreements, product utilization agreements, R&D agreements and others, along with analysis on recent investments during the period 2018-2022, including grants, debt, seed funding, venture series, IPO, private equity, private placement, other equity and others. Further, the chapter includes analysis of other recent initiatives taken by various stakeholders engaged in this domain.

Chapter 10 provides an insightful analysis on filed / granted patents focused on tissue engineering-based regeneration products, during the period 2000-2022. The analysis highlights key details and trends associated with the patents in this domain, including patent type (granted patents / patent application / search reports / limited patent), publication year, geographical location (North America / Europe / Asia-Pacific / WIPO), assigned CPC symbol, emerging focus area, type of applicant (industry / non-industry) and leading industry / non-industry players (in terms of size of intellectual property portfolio). It also includes a patent benchmarking analysis and a detailed valuation analysis.

Chapter 11 provides information on more than 750 grants that were awarded to several research institutes engaged in projects related to tissue engineering-based regeneration products, between 2018 and 2022 (till the time of analysis). The analysis also highlights important parameters associated with grants, such as year of award, support period, amount awarded, funding institute, administration institute center, funding institute center, funding mechanism, spending categorization, grant type (research grants (r series) / research training and fellowships (t & f series) / program project/center grants (p series) / others), responsible study section, focus area, type of recipient organization (schools of medicine / biomedical engineering / college of engineering / schools of arts and sciences / independent hospitals / domestic for-profits / other domestic non-profits / schools of dentistry /oral hygiene / research institutes / domestic higher education / others) and prominent program officers. 

Chapter 12 presents an insightful market forecast analysis, highlighting the future potential of tissue engineering-based skin regeneration products market till 2035. In order to provide details on the future opportunity, our projections have been segmented across important market segments, namely [A] type of graft (allografts, autografts and xenografts), [B] area of application (burn healing, surgical healing, wound healing and others), [C] type of material of scaffold (collagen-based tissues,  human placental tissues, other human tissues, other animal-based tissues and other tissues ), [D] type of end user (ambulatory surgical centers / hospitals / specialty clinics) , [E] key geographies (North America, Europe, Asia, Latin America, Middle East and North Africa and rest of the world).

Chapter 13 presents an insightful market forecast analysis, highlighting the future potential of tissue engineering-based bone regeneration products market till 2035. In order to provide details on the future opportunity, our projections have been segmented across important market segments, namely [A] type of graft (allografts and xenografts), [B] type of material of scaffold (bone tissues, collagen tissues, stem cells and others), [C] type of End User (ambulatory surgical centers / hospitals / specialty clinics), [D] key geographies (North America, Europe, Asia, Latin America, Middle East and North Africa and rest of the world).

Chapter 14 presents the summary of the overall report. Additionally, in this chapter, we have provided a list of key takeaways from the report, and expressed our independent opinion related to the research and analysis described in the previous chapters.

Chapter 15 provides the insights from primary research conducted with several stakeholders in this domain.

Chapter 16 is an appendix, which contains the list of companies and organizations mentioned in the report.

Chapter 17 is an appendix, which provides tabulated data and numbers for all the figures provided in the report.

Table Of Contents

1. PREFACE
1.1. Scope of the Report
1.2 Market Segmentation
1.3. Research Methodology
1.4. Key Questions Answered
1.5. Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION
3.1 Chapter Overview
3.2. Introduction to Tissue Engineering
3.2.1. Types of Cells Used in Tissue Engineering
3.2.2. Application of Tissue Engineering in Regenerative Medicine
3.2.3. Tissue Engineered Regenerative Products
3.3 Applications of Tissue Engineering-based Regenerative Products
3.4 Challenges Associated with Tissue Engineering-based Regenerative Products
3.5 Future Prospective

4. MARKET LANDSCAPE: TISSUE ENGINEERING-BASED SKIN REGENERATION PRODUCTS
4.1. Chapter Overview
4.2. Tissue Engineering-based Skin Regeneration Products: Market Landscape
4.2.1. Analysis by Type of Graft
4.2.2. Analysis by Area of Application
4.2.3. Analysis by Type of Material of Scaffold
4.2.4 Analysis by Launch Year
4.3. Tissue Engineering-based Skin Regeneration Products: Developer Landscape
4.3.1. Analysis by Year of Establishment
4.3.2. Analysis by Company Size
4.3.3. Analysis by Location of Headquarters
4.3.4. Analysis by Target Market

5. MARKET LANDSCAPE: TISSUE ENGINEERING- BASED BONE REGENERATION PRODUCTS
5.1. Chapter Overview
5.2. Tissue Engineering-based Bone Regeneration Products: Market Landscape
5.2.1. Analysis by Type of Graft
5.2.3. Analysis by Formulation of Products
5.2.4. Analysis by Type of Material of Scaffold
5.2.5 Analysis by Launch Year
5.3. Tissue Engineering-based Skin Regeneration Products: Developer Landscape
5.3.1. Analysis by Year of Establishment
5.3.2. Analysis by Company Size
5.3.3. Analysis by Location of Headquarters
5.3.4. Analysis by Target Market

6. KEY INSIGHTS
6.1. Chapter Overview
6.2. Analysis by Location of Headquarters (World Map Representation)
6.3. Analysis by Year of Establishment, Company Size, Number of Tissue engineering-based Regeneration Products Offered and Region (4D Bubble Chart)
6.4. Analysis by Type of Graft and Area of Application (Spider Web Representation)
6.5. Analysis by Area of Application and Type of Material of Scaffold (Horizontal Stacked Bar Chart)
6.6. Analysis by Product Formulation and Type of Graft (Vertical Stacked Bar Chart)
6.7. Analysis by Region and Target Market (Vertical Stacked Bar Chart)

7. COMPANY COMPETITIVENESS
7.1. Chapter Overview
7.2. Key Assumptions and Parameters
7.3. Methodology
7.3.1. Company Competitiveness Analysis: Very Small Companies
7.3.2. Company Competitiveness Analysis: Small Companies
7.3.3. Company Competitiveness Analysis: Mid-sized Companies
7.3.4. Company Competitiveness Analysis: Large Companies
7.3.5. Company Competitiveness Analysis: Very Large Companies

8. COMPANY PROFILES
8.1. Chapter Overview
8.2. AlloSource
8.2.1. Company Overview
8.2.2. Tissue Engineering-based Regeneration Products Portfolio
8.2.3. Recent Developments and Future Outlook

8.3. BioTissue 
8.3.1. Company Overview
8.3.2. Tissue Engineering-based Regeneration Products Portfolio 
8.3.3. Recent Developments and Future Outlook

8.4. Integra LifeSciences 
8.4.1. Company Overview
8.4.2. Tissue Engineering-based Regeneration Products Portfolio
8.4.3. Recent Developments and Future Outlook

8.5 MiMedx 
8.5.1. Company Overview
8.5.2. Tissue Engineering-based Regeneration Products Portfolio 
8.5.3. Recent Developments and Future Outlook 

8.6. Organogenesis
8.6.1. Company Overview
8.6.2. Tissue Engineering-based Regeneration Products Portfolio
8.6.3. Recent Developments and Future Outlook

8.7. Smith +Nephew 
8.7.1. Company Overview
8.7.2. Tissue Engineering-based Regeneration Products Portfolio
8.7.3. Recent Developments and Future Outlook 

8.8. Tissue Regenix 
8.8.1. Company Overview
8.8.2. Tissue Engineering-based Regeneration Products Portfolio
8.8.3. Recent Developments and Future Outlook

8.9. VIVEX Biologics 
8.9.1. Company Overview
8.9.2. Tissue Engineering-based Regeneration Products Portfolio
8.9.3. Recent Developments and Future Outlook 

9. RECENT DEVELOPMENTS AND INITIATIVES
9.1. Chapter Overview
9.2. Tissue Engineering-based Regeneration Products Market: Partnerships and Collaborations
9.2.1. Partnership Models
9.2.2. List of Partnerships and Collaborations
9.2.3. Analysis by Number of Partnership Instances
9.2.4. Analysis by Type of Partnership
9.2.5. Analysis by Year and Type of Partnership
9.2.6. Analysis by Type of Partnership and Company Size
9.2.7. Most Active Players: Analysis by Number of Partnerships
9.2.8. Analysis by Region
9.2.9. Intercontinental and Intracontinental Agreements
9.3. Tissue Engineering-based Regeneration Products Market: Funding and Investments
9.3.1. Type of Funding
9.3.2. List of Funding and Investments
9.3.3. Analysis by Number of Funding Instances
9.3.4. Analysis by Amount Invested 
9.3.5. Analysis by Type of Funding
9.3.6. Analysis by Region
9.3.7. Most Active Players: Analysis by Number of Funding Instances
9.3.8. Most Active Players: Analysis by Amount Raised
9.4. Tissue Engineering-based Regeneration Products Market: Recent Initiatives
9.4.1. Analysis by Number of Initiatives
9.4.2. Analysis by Type of Initiative
9.4.3. Analysis by Region

10. PATENT ANALYSIS
10.1. Chapter Overview
10.2. Scope and Methodology
10.3. Tissue Engineering-based Regeneration Products: Patent Analysis
10.3.1. Analysis by Type of Patent
10.3.2. Analysis by Publication Year
10.3.3. Analysis of Granted Patents by Publication Year
10.3.4. Analysis by Filed Patents by Publication Year
10.3.5. Analysis by Year of Patent Publication and Type of Player
10.3.6. Analysis by Issuing Authority
10.3.7. Analysis by Patent Focus
10.3.8. Analysis by Patent Age
10.3.9. Analysis by CPC Symbols
10.3.10. Leading Players: Analysis by Number of Patents
10.4. Tissue Engineering-based Regeneration Products: Patent Benchmarking Analysis
10.4.1. Analysis by Patent Characteristics
10.5. Tissue Engineering-based Regeneration Products: Patent Valuation Analysis

11. GRANTS ANALYSIS
11.1. Chapter Overview
11.2. Scope and Methodology
11.3. Analysis of Academic Grants
11.3.1. Analysis of Instances by Year
11.3.2. Analysis of Amount Awarded by Year
11.3.3. Analysis by Support Period
11.3.4. Analysis by Funding Institute and Support Period
11.3.5. Analysis by Type of Grant Application
11.3.6. Analysis by Purpose of Grant Award
11.3.7. Analysis by Activity Code
11.3.8. Analysis by NIH Spending Category (Word Cloud Representation)
11.3.9. Analysis by Study Section Involved
11.3.10. Popular NIH Departments: Analysis by Number of Grants
11.3.11. Analysis by Type of Recipient Organization
11.3.12. Prominent Program Officers: Analysis by Number of Grants
11.3.13. Popular Recipient Organizations: Analysis by Number of Grants
11.3.14. Popular Recipient Organizations: Analysis by Grant Amount
11.3.15. Regional Distribution of Recipient Organizations
11.3.16 Leading Funding Institutes: Analysis by Number of Grants

12. MARKET FORECAST: TISSUE ENGINEERING-BASED SKIN REGENERATION PRODUCTS
12.1. Chapter Overview
12.2. Key Assumptions and Methodology
12.3. Tissue Engineering-based Skin Regeneration Products Market, 2022-2035
12.3.1. Tissue Engineering-based Skin Regeneration Products Market: Analysis by Type of Graft, 2022 and 2035
12.3.1.1. Tissue Engineering-based Skin Regeneration Products Market for Allografts
12.3.1.2. Tissue Engineering-based Skin Regeneration Products Market for Autografts
12.3.1.3. Tissue Engineering-based Skin Regeneration Products Market for Xenografts
12.3.2. Tissue Engineering-based Skin Regeneration Products Market: Analysis by Area of Application, 2022 and 2035
12.3.2.1. Tissue Engineering-based Skin Regeneration Products Market for Burn Healing
12.3.2.2. Tissue Engineering-based Skin Regeneration Products Market for SurgicalHealing 
12.3.2.3. Tissue Engineering-based Skin Regeneration Products Market for WoundHealing
12.3.2.4. Tissue Engineering-based Skin Regeneration Products Market for Others
12.3.3. Tissue Engineering-based Skin Regeneration Products Market: Analysis by Material of Scaffold, 2022 and 2035
12.3.3.3. Tissue Engineering-based Skin Regeneration Products Market for CollagenTissues 
12.3.3.1. Tissue Engineering based Skin Regeneration Products Market for Human Placental Tissues
12.3.3.2. Tissue Engineering-based Skin Regeneration Products Market for
 Other Human Tissues
12.3.3.4. Tissue Engineering-based Skin Regeneration Products Market for OtherAnimal Tissues
12.3.3.5. Tissue Engineering-based Skin Regeneration Products Market for Other Materialof Scaffold
12.2.4. Tissue Engineering-based Skin Regeneration Products Market: Analysis by End User 2022 and 2035
12.3.4.1. Tissue Engineering-based Skin Regeneration Products Market for Ambulatory Surgical Centers
12.3.4.2. Tissue Engineering-based Skin Regeneration Products Market for Hospitals
12.3.4.3. Tissue Engineering-based Skin Regeneration Products Market for SpecialtyClinics

12.3.5. Tissue Engineering-based Skin Regeneration Products Market: Analysis by Geography, 2022 and 2035
12.3.5.1. Tissue Engineering-based Skin Regeneration Products Market in North America
12.3.5.1.1. Tissue Engineering-based Skin Regeneration Products Market in the US
12.3.5.1.2. Tissue Engineering-based Skin Regeneration Products Market in Canada
12.3.5.2. Tissue Engineering-based Skin Regeneration Products Market in Europe
12.3.5.2.1. Tissue Engineering-based Skin Regeneration Products Market in France
12.3.5.2.2. Tissue Engineering-based Skin Regeneration Products Market in Germany
12.3.5.2.3. Tissue Engineering-based Skin Regeneration Products Market in Italy
12.3.5.2.4. Tissue Engineering-based Skin Regeneration Products Market in the Netherlands
12.3.5.2.5. Tissue Engineering-based Skin Regeneration Products Market in Spain
12.3.5.2.6. Tissue Engineering-based Skin Regeneration Products Market in the UK
12.3.5.3. Tissue Engineering-based Skin Regeneration Products Market in Asia
12.3.5.3.1. Tissue Engineering-based Skin Regeneration Products Market in China
12.3.5.3.2. Tissue Engineering-based Skin Regeneration Products Market in India
12.3.5.3.3. Tissue Engineering-based Skin Regeneration Products Market in Japan
12.3.5.3.4. Tissue Engineering-based Skin Regeneration Products Market in South Korea
12.3.5.4. Tissue Engineering-based Regeneration Products Market in Middle East andNorth Africa
12.3.5.4.1. Tissue Engineering-based Skin Regeneration Products Market in Israel
12.3.5.4.2. Tissue Engineering-based Skin Regeneration Products Market in Turkey
12.3.5.5. Tissue Engineering-based Skin Regeneration Products Market in Latin America
12.3.5.5.1. Tissue Engineering-based Skin Regeneration Products Market in Brazil
12.3.5.6. Tissue Engineering-based Skin Regeneration Products Market in Rest of theWorld
12.3.5.6.1. Tissue Engineering-based Skin Regeneration Products Market in Australia
12.3.5.6.2. Tissue Engineering-based Skin Regeneration Products Market in New Zealand

13. MARKET FORECAST: TISSUE ENGINEERING-BASED BONE REGENERATION PRODUCTS
13.1. Chapter Overview
13.2. Key Assumptions and Methodology
13.3. Tissue Engineering-based Bone Regeneration Products Market, 2022-2035
13.3.1. Tissue Engineering-based Bone Regeneration Products Market: Analysis by Type of Graft, 2022 and 2035
13.3.1.1. Tissue Engineering-based Bone Regeneration Products Market for Allografts
13.3.1.2. Tissue Engineering-based Bone Regeneration Products Market for Xenografts
13.3.2. Tissue Engineering-based Bone Regeneration Products Market: Analysis by Type of Material of Scaffold, 2022 and 2035
13.3.2.1. Tissue Engineering-based Bone Regeneration Products Market for Bone Tissues
13.3.2.2. Tissue Engineering-based Bone Regeneration Products Market for Collagen Tissues
13.3.2.3. Tissue Engineering-based Bone Regeneration Products Market for Stem Cells
13.3.2.4. Tissue Engineering-based Bone Regeneration Products Market for OtherMaterials of Scaffold
13.3.3. Tissue Engineering-based Bone Regeneration Products Market: Analysis by End User 2022 and 2035
13.3.3.1. Tissue Engineering-based Bone Regeneration Products Market for Ambulatory Surgical Centers
13.3.3.2. Tissue Engineering-based Bone Regeneration Products Market for Hospitals
13.3.3.3. Tissue Engineering-based Bone Regeneration Products Market for SpecialtyClinics
13.3.4. Tissue Engineering-based Bone Regeneration Products Market: Analysis by Geography 2022 and 2035
13.3.4.1. Tissue Engineering-based Bone Regeneration Products Market in North America
13.3.4.1.1. Tissue Engineering-based Bone Regeneration Products Market in the US
13.3.4.1.2. Tissue Engineering-based Bone Regeneration Products Market in Canada
13.3.4.2. Tissue Engineering-based Bone Regeneration Products Market in Europe
13.3.4.2.1. Tissue Engineering-based Bone Regeneration Products Market in France
13.3.4.2.2. Tissue Engineering-based Bone Regeneration Products Market in Germany
13.3.4.2.3. Tissue Engineering-based Bone Regeneration Products Market in Italy
13.3.4.2.4. Tissue Engineering-based Bone Regeneration Products Market in the Netherlands
13.3.4.2.5. Tissue Engineering-based Bone Regeneration Products Market in Spain
13.3.4.2.6 Tissue Engineering-based Bone Regeneration Products Market in the UK
13.3.4.3. Tissue Engineering-based Bone Regeneration Products Market in Asia
13.3.4.3.1. Tissue Engineering-based Bone Regeneration Products Market in China
13.3.4.3.2. Tissue Engineering-based Bone Regeneration Products Market in India
13.3.4.3.3. Tissue Engineering-based Bone Regeneration Products Market in Japan
13.3.4.3.4. Tissue Engineering-based Bone Regeneration Products Market in South Korea
13.3.4.4. Tissue Engineering-based Regeneration Products Market in Middle East and North Africa
13.3.4.4.1. Tissue Engineering-based Bone Regeneration Products Market in Israel
13.3.4.4.2. Tissue Engineering-based Bone Regeneration Products Market in Turkey
13.3.4.5. Tissue Engineering-based Bone Regeneration Products Market in Latin America
13.3.4.5.1. Tissue Engineering-based Bone Regeneration Products Market in Brazil
13.3.4.6. Tissue Engineering-based Bone Regeneration Products Market in Rest of theWorld
13.3.4.6.1. Tissue Engineering-based Bone Regeneration Products Market in Australia
13.3.4.6.2. Tissue Engineering-based Bone Regeneration Products Market in New Zealand

14. CONCLUSION

15. EXECUTIVE INSIGHTS FROM PRIMARY RESEARCH

16. APPENDIX I: TABULATED DATA

17. APPENDIX II: LIST OF COMPANIES AND ORGANIZATIONS

List Of Figures

Figure 3.1 Types of Cells Used in Tissue Engineering
Figure 3.2 Applications of Tissue Engineering-based Regeneration Products
Figure 3.3 Challenges with Tissue Engineering-based Regeneration Products
Figure 4.1 Tissue Engineering-based Skin Regeneration Products: Distribution by Type ofGraft 
Figure 4.2 Tissue Engineering-based Skin Regeneration Products: Distribution by Area ofApplication
Figure 4.3 Tissue Engineering-Based Skin Regeneration Products: Distribution by Type ofMaterial of Scaffold
Figure 4.4 Tissue Engineering-based Skin Regeneration Products: Distribution by Launchyear
Figure 4.5 Tissue Engineering-based Skin Regeneration Products Developers: Distribution by Year of Establishment
Figure 4.6 Tissue Engineering-based Skin Regeneration Products Developers: Distribution by Company Size
Figure 4.7 Tissue Engineering-based Skin Regeneration Products Developers: Distribution by Location of Headquarters
Figure 4.8 Tissue Engineering-based Skin Regeneration Products Developers: Distribution by Target Market
Figure 5.1 Tissue Engineering-based Bone Regeneration Products: Distribution by Type of Graft
Figure 5.2 Tissue Engineering-based Bone Regeneration Products: Distribution by Formulation of Products
Figure 5.3 Tissue Engineering-based Bone Regeneration Products: Distribution by Type ofMaterial of Scaffold
Figure 5.4 Tissue Engineering-based Bone Regeneration Products: Distribution by Launchyear
Figure 5.5 Tissue Engineering-based Bone Regeneration Products Developers: Distribution by Year of Establishment
Figure 5.6 Tissue Engineering-based Bone Regeneration Products Developers: Distribution by Company Size
Figure 5.7 Tissue Engineering-based Bone Regeneration Products Developers: Distribution by Location of Headquarters
Figure 5.8 Tissue Engineering-based Bone Regeneration Products Developers: Distribution by Target Market
Figure 6.1 World Map Representation: Distribution by Location of Headquarters
Figure 6.2 4D Bubble Chart Representation: Distribution by Year of Establishment, CompanySize, Number of Tissue Engineering-based Regeneration Products Offered and Region
Figure 6.3 Spider Web Representation: Distribution by Type of Graft and Area of Application
Figure 6.4 Horizontal Stacked Bar Chart Representation: Distribution by Area of Application and Type of Material of Scaffold
Figure 6.5 Vertical Stacked Bar Chart Representation: Distribution by Product Formulation and Type of Graft
Figure 6.6 Vertical Stacked Bar Chart Representation: Distribution by Region and TargetMarket
Figure 7.1 Company Competitiveness Analysis: Very Small Companies
Figure 7.2 Company Competitiveness Analysis: Small Companies
Figure 7.3 Company Competitiveness Analysis: Mid-sized Companies
Figure 7.4 Company Competitiveness Analysis: Large Companies
Figure 7.5 Company Competitiveness Analysis: Very Large Companies
Figure 9.1 Partnerships and Collaborations: Cumulative Year-wise Trend, 2017-2022
Figure 9.2 Partnerships and Collaborations: Distribution by Type of Partnership
Figure 9.3 Partnerships and Collaborations: Distribution by Year and Type of Partnership
Figure 9.4 Partnerships and Collaborations: Distribution by Type of Partnership andCompany Size
Figure 9.5 Most Active Players: Distribution by Number of Partnerships
Figure 9.6 Partnerships and Collaborations: Local and International Agreements
Figure 9.7 Partnerships and Collaborations: Distribution by Geography
Figure 9.8 Partnerships and Collaborations: Intercontinental and Intracontinental Agreements
Figure 9.9 Funding and Investment Analysis: Cumulative Year-wise Trend of Instances,2018-2022
Figure 9.10 Funding and Investment Analysis: Cumulative Year-wise Trend of AmountInvested, 2018-2022 (USD Million)
Figure 9.11 Funding and Investment Analysis: Distribution by Type of Funding
Figure 9.12 Funding and Investment Analysis: Distribution of Instances by Region
Figure 9.13 Funding and Investment Analysis: Distribution of Total Amount Invested byRegion
Figure 9.14 Most Active Players: Distribution by Number of Funding Instances
Figure 9.15 Most Active Players: Distribution by Amount Raised (USD Million)
Figure 9.16 Recent Initiatives Analysis: Cumulative Year-wise Trend of Instances, 2018-2022
Figure 9.17 Recent Initiatives Analysis: Distribution by Type of Initiative
Figure 9.18 Recent Initiatives Analysis: Distribution of Instances by Region
Figure 10.1 Patent Analysis: Distribution by Type of Patent
Figure 10.2 Patent Analysis: Cumulative Distribution by Publication Year, 2003-2022
Figure 10.3 Patent Analysis: Cumulative Distribution of Granted Patents by Publication Year,2012-2022
Figure 10.4 Patent Analysis: Cumulative Distribution of Filed Patents by Publication Year,2012-2022
Figure 10.5 Patent Analysis: Cumulative Distribution of Patents by Publication Year and Typeof Player, 2012-2022
Figure 10.6 Patent Analysis: Distribution by Issuing Authority
Figure 10.7 Patent Analysis: Distribution by Patent Focus
Figure 10.8 Patent Analysis: Distribution by Patent Age
Figure 10.9 Patent Analysis: Distribution by CPC Symbols
Figure 10.10 Leading Industry Players: Distribution by Number of Patents
Figure 10.11 Leading Non-Industry Players: Distribution by Number of Patents
Figure 10.12 Leading Inventors: Distribution by Number of Patents
Figure 10.13 Patent Analysis (Top 10 CPC Symbols): Benchmarking by Leading Players
Figure 10.14 Patent Analysis (Leading Players): Benchmarking by Top 10 CPC Symbols
Figure 10.15 Patent Analysis: Valuation Analysis
Figure 11.1 Grant Analysis: Cumulative Year-Wise Trend, 2017- 2022
Figure 11.2 Grant Analysis: Distribution by Amount Awarded by Year
Figure 11.3 Grant Analysis: Distribution by Amount Awarded (USD Million), 2017-2022
Figure 11.4 Grant Analysis: Distribution by Support Period
Figure 11.5 Grant Analysis: Distribution by Funding Institute and Support
Figure 11.6 Grant Analysis: Distribution by Type of Grant Application
Figure 11.7 Grant Analysis: Distribution by Purpose of Grant Award
Figure 11.8 Grant Analysis: Distribution by Activity Code
Figure 11.9 Word Cloud Representation: NIH spending Category
Figure 11.10 Grant Analysis: Distribution by Study Section Involved
Figure 11.11 Popular NIH Departments: Distribution by Number of Grants
Figure 11.12 Grant Analysis: Distribution by Type of Recipient Organization
Figure 11.13 Most Prominent Program Officers: Distribution by Number of Grants
Figure 11.14 Popular Recipient Organization: Distribution by Number of Grants
Figure 11.15 Popular Recipient Organization: Distribution by Grant Amount
Figure 11.16 Grant Analysis: Regional Distribution of Recipient Organization
Figure 11.17 Grant Analysis: Leading Funding Institutes: Distribution by Number of Grants
Figure 12.1 Tissue Engineering-based Skin Regeneration Products Market, 2022-2035 (USDMillion)
Figure 12.2 Tissue Engineering-based Skin Regeneration Products Market: Distribution byType of Graft, 2022 and 2035
Figure 12.3 Tissue Engineering-based Skin Regeneration Products Market for Allografts,2022-2035 (USD Million)
Figure 12.4 Tissue Engineering-based Skin Regeneration Products Market for Autografts,2022-2035 (USD Million)
Figure 12.5 Tissue Engineering-based Skin Regeneration Products Market for Xenografts,2022-2035 (USD Million)
Figure 12.6 Tissue Engineering-based Skin Regeneration Products Market: Distribution byArea of Application, 2022 and 2035 
Figure 12.7 Tissue Engineering-based Skin Regeneration Products Market for Burn Healing,2022-2035 (USD Million)
Figure 12.8 Tissue Engineering-based Skin Regeneration Products Market for SurgicalHealing, 2022-2035 (USD Million)
Figure 12.9 Tissue Engineering-based Skin Regeneration Products Market for WoundHealing, 2022-2035 (USD Million)
Figure 12.10 Tissue Engineering-based Skin Regeneration Products Market for Others, 2022-
 2035 (USD Million)
Figure 12.11 Tissue Engineering-based Skin Regeneration Products Market: Distribution byMaterial of Scaffold, 2022 and 2035
Figure 12.12 Tissue Engineering-based Skin Regeneration Products Market for CollagenTissues, 2022-2035 (USD Million)
Figure 12.13 Tissue Engineering-based Skin Regeneration Products Market for HumanPlacental Tissues (USD Million)
Figure 12.14 Tissue Engineering-based Skin Regeneration Products Market for Other HumanTissues, 2022-2035 (USD Million)
Figure 12.15 Tissue Engineering-based Skin Regeneration Products Market for Other AnimalTissues, 2022-2035 (USD Million)
Figure 12.16 Tissue Engineering-based Skin Regeneration Products Market for Other Materialof Scaffold, 2022-2035 (USD Million)
Figure 12.17 Tissue Engineering-based Bone Regeneration Products Market: Distribution byEnd User 2022 and 2035
Figure 12.18 Tissue Engineering-based Bone Regeneration Products Market for Ambulatory Surgical Centers, 2022-2035 (USD Million)
Figure 12.19 Tissue Engineering-based Bone Regeneration Products Market for Hospitals, 2022-2035 (USD Million)
Figure 12.20 Tissue Engineering-based Bone Regeneration Products Market for SpecialtyClinics, 2022-2035 (USD Million)
Figure 12.21 Tissue Engineering-based Skin Regeneration Products Market: Distribution byGeography, 2022 and 2035 
Figure 12.22 Tissue Engineering-based Skin Regeneration Products Market in NorthAmerica,2022-2035 (USD Million)
Figure 12.23 Tissue Engineering-based Skin Regeneration Products Market in the US, 2022-2035, (USD Million)
Figure 12.24 Tissue Engineering-based Skin Regeneration Products Market in Canada, 2022-2035 (USD Million)
Figure 12.25 Tissue Engineering-based Skin Regeneration Products Market in Europe, 2022-2035 (USD Million)
Figure 12.26 Tissue Engineering-based Skin Regeneration Products Market in France, 2022-2035 (USD Million)
Figure 12.27 Tissue Engineering-based Skin Regeneration Products Market in Germany, 2022-2035 (USD Million)
Figure 12.28 Tissue Engineering-based Skin Regeneration Products Market in Italy, 2022-2035(USD Million)
Figure 12.29 Tissue Engineering-based Skin Regeneration Products Market in the Netherlands,2022-2035 (USD Million)
Figure 12.30 Tissue Engineering-based Skin Regeneration Products Market in Spain, 2022-2035(USD Million)
Figure 12.31 Tissue Engineering-based Skin Regeneration Products Market in the UK, 2022-2035(USD Million)
Figure 12.32 Tissue Engineering-based Skin Regeneration Products Market in Asia, 2022-2035(USD Million)
Figure 12.33 Tissue Engineering-based Skin Regeneration Products Market in China, 2022-2035 (USD Million)
Figure 12.34 Tissue Engineering-based Skin Regeneration Products Market in India, 2022-2035(USD Million)
Figure 12.35 Tissue Engineering-based Skin Regeneration Products Market in Japan, 2022-2035 (USD Million)
Figure 12.36 Tissue Engineering-based Skin Regeneration Products Market in SouthKorea,2022-2035 (USD Million)
Figure 12.37 Tissue Engineering-based Regeneration Products Market in Middle East and NorthAfrica, 2022-2035 (USD Million)
Figure 12.38 Tissue Engineering-based Skin Regeneration Products Market in Israel, 2022-2035(USD Million)
Figure 12.39 Tissue Engineering-based Skin Regeneration Products Market in Turkey, 2022-2035(USD Million)
Figure 12.40 Tissue Engineering-based Skin Regeneration Products Market in Latin America,2022-2035 (USD Million)
Figure 12.37 Tissue Engineering-based Skin Regeneration Products Market in Brazil, 2022-2035 (USD Million)
Figure 12.38 Tissue Engineering-based Skin Regeneration Products Market in Rest of theWorld, 2022-2035 (USD Million)
Figure 12.39 Tissue Engineering-based Skin Regeneration Products Market in Australia, 2022-2035(USD Million)
Figure 12.40 Tissue Engineering-based Skin Regeneration Products Market in New Zealand,2022-2035 (USD Million)
Figure 13.1 Tissue Engineering-based Bone Regeneration Products Market, 2022-2035,   (USD Million)
Figure 13.2 Tissue Engineering-based Bone Regeneration Products Market: Distribution byType of Graft, 2022 and 2035 
Figure 13.3 Tissue Engineering-based Bone Regeneration Products Market for Allografts,2022-2035 (USD Million)
Figure 13.4 Tissue Engineering-based Bone Regeneration Products Market for Xenografts,2022-2035 (USD Million)
Figure 13.5 Tissue Engineering-based Bone Regeneration Products Market: Distribution byMaterial of Scaffold, 2022 and 2035
Figure 13.6 Tissue Engineering-based Bone Regeneration Products Market for BoneTissues,2022-2035 (USD Million)
Figure 13.7 Tissue Engineering-based Bone Regeneration Products Market for CollagenTissues, 2022-2035 (USD Million)
Figure 13.8 Tissue Engineering-based Bone Regeneration Products Market for Stem Cells,2022-2035 (USD Million)
Figure 13.9 Tissue Engineering-based Bone Regeneration Products Market for Other Materialof Scaffold, 2022-2035 (USD Million)
Figure 13.10 Tissue Engineering-based Bone Regeneration Products Market: Distribution byEnd User 2022 and 2035
Figure 13.11 Tissue Engineering-based Bone Regeneration Products Market for Ambulatory Surgical Centers, 2022-2035 (USD Million)
Figure 13.12 Tissue Engineering-based Bone Regeneration Products Market for Hospitals, 2022-2035 (USD Million)
Figure 13.13 Tissue Engineering-based Bone Regeneration Products Market for SpecialtyClinics, 2022-2035 (USD Million)
Figure 13.14 Tissue Engineering-based Bone Regeneration Products Market: Distribution byGeography, 2022 and 2035 
Figure 13.15 Tissue Engineering-based Bone Regeneration Products Market in NorthAmerica, 2022-2035 (USD Million)
Figure 13.16 Tissue Engineering-based Bone Regeneration Products Market in the US,2022-2035, (USD Million)
Figure 13.17 Tissue Engineering-based Bone Regeneration Products Market in Canada, 2022-2035 (USD Million)
Figure 13.18 Tissue Engineering-based Bone Regeneration Products Market in Europe, 2022-2035 (USD Million)
Figure 13.19 Tissue Engineering-based Bone Regeneration Products Market in France, 2022-2035 (USD Million)
Figure 13.20 Tissue Engineering-based Bone Regeneration Products Market in Germany, 2022-2035 (USD Million)
Figure 13.21 Tissue Engineering-based Bone Regeneration Products Market in Italy, 2022-2035(USD Million)
Figure 13.22 Tissue Engineering-based Bone Regeneration Products Market in theNetherlands, 2022-2035 (USD Million)
Figure 13.23 Tissue Engineering-based Bone Regeneration Products Market in Spain, 2022-2035 (USD Million)
Figure 13.24 Tissue Engineering-based Bone Regeneration Products Market in the UK, 2022-2035 (USD Million)
Figure 13.25 Tissue Engineering-based Bone Regeneration Products Market in Asia, 2022-2035(USD Million)
Figure 13.26 Tissue Engineering-based Bone Regeneration Products Market in China, 2022-2035 (USD Million)
Figure 13.27 Tissue Engineering-based Bone Regeneration Products Market in India, 2022-2035 (USD Million)
Figure 13.28 Tissue Engineering-based Bone Regeneration Products Market in Japan, 2022-2035 (USD Million)
Figure 13.29 Tissue Engineering-based Bone Regeneration Products Market in SouthKorea,2022-2035 (USD Million)
Figure 13.30 Tissue Engineering-based Regeneration Products Market in Middle East and NorthAfrica, 2022-2035 (USD Million)
Figure 13.31 Tissue Engineering-based Bone Regeneration Products Market in Israel, 2022-2035(USD Million)
Figure 13.32 Tissue Engineering-based Bone Regeneration Products Market in Turkey, 2022-2035 (USD Million)
Figure 13.33 Tissue Engineering-based Bone Regeneration Products Market in LatinAmerica,2022-2035 (USD Million)
Figure 13.34 Tissue Engineering-based Bone Regeneration Products Market in Brazil, 2022-2035 (USD Million)
Figure 13.35 Tissue Engineering-based Bone Regeneration Products Market in Rest of the World, 2022-2035 (USD Million)
Figure 13.36 Tissue Engineering-based Bone Regeneration Products Market in Australia, 2022-2035 (USD Million)
Figure 13.37 Tissue Engineering-based Bone Regeneration Products Market in NewZealand,2022-2035 (USD Million)
Figure 14.1 Concluding Remarks: Current Market Landscape (Skin Healing Products)
Figure 14.2 Concluding Remarks: Current Market Landscape (Bone Healing Products)
Figure 14.3 Concluding Remarks: Recent Developments and Initiatives
Figure 14.4 Concluding Remarks: Patent Analysis
Figure 14.5 Concluding Remarks: Grant Analysis
Figure 14.6 Concluding Remarks: Market Forecast

List Of Tables

Table 4.1 Tissue Engineering-based Skin Regeneration Products: Information on Type ofGraft 
Table 4.2 Tissue Engineering-based Skin Regeneration Products: Information on Area ofApplication
Table 4.3 Tissue Engineering-based Skin Regeneration Products: Information on Material of Scaffold
Table 4.4 Tissue Engineering-based Skin Regeneration Products: Information on Launch Year
Table 4.5 Tissue Engineering based Skin Regeneration Products Providers: Information on Year of Establishment, Company Size, Location of Headquarters, and Target market
Table 5.1 Tissue Engineering-based Bone Regeneration Products: Information on Type ofGraft 
Table 5.2 Tissue Engineering-based Bone Regeneration Products: Information on Formulation of Products
Table 5.3 Tissue Engineering-based Bone Regeneration Products: Information on Materialof Scaffold
Table 5.4 Tissue Engineering-based Bone Regeneration Products: Information on Launchyear
Table 5.5 Tissue Engineering based Bone Regeneration Products Providers: Information on Year of Establishment, Company Size, Location of Headquarters and Target market
Table 6.1 Company Competitiveness Analysis: List of Small Players
Table 6.2 Company Competitiveness Analysis: List of Mid-sized Players
Table 6.3 Company Competitiveness Analysis: List of Large Players
Table 6.4 Company Competitiveness Analysis: List of Very Large Players
Table 7.1 List of Companies Profiled
Table 7.2 AlloSource: Company Overview
Table 7.3 AlloSource: Tissue Engineering-based Regeneration Product Portfolio
Table 7.4 AlloSource: Recent Developments and Future Outlook
Table 7.5 BioTissue: Company Overview
Table 7.6 BioTissue: Tissue Engineering-based Regeneration Product Portfolio
Table 7.7 BioTissue: Recent Developments and Future Outlook
Table 7.8 Integra LifeSciences: Company Overview
Table 7.9 Integra LifeSciences: Tissue Engineering-based Regeneration Product Portfolio
Table 7.10 Integra LifeSciences: Recent Developments and Future Outlook
Table 7.11 MiMedx: Company Overview
Table 7.12 MiMedx: Tissue Engineering-based Regeneration Product Portfolio
Table 7.13 MiMedx: Recent Developments and Future Outlook
Table 7.14 Organogenesis: Company Overview
Table 7.15 Organogenesis: Tissue Engineering-based Regeneration Product Portfolio
Table 7.16 Organogenesis: Recent Developments and Future Outlook
Table 7.17 Smith +Nephew: Company Overview
Table 7.18 Smith +Nephew: Tissue Engineering-based Regeneration Product Portfolio
Table 7.19 Smith +Nephew: Recent Developments and Future Outlook
Table 7.20 Tissue Regenix: Company Overview
Table 7.21 Tissue Regenix: Tissue Engineering-based Regeneration Product Portfolio
Table 7.22 Tissue Regenix: Recent Developments and Future Outlook
Table 7.20 VIVEX Biologics: Company Overview
Table 7.23 VIVEX Biologics: Tissue Engineering-based Regeneration Product Portfolio
Table 7.24 VIVEX Biologics: Recent Developments and Future Outlook
Table 8.1 Partnerships and Collaborations: Information on Year of Agreement, Type ofPartnership and Partner, 2017-2022
Table 8.2 Funding and Investments: Information on Year of Establishment, Location of Headquarters of Recipients, Month-Year of Investment, Type of Funding, Amount Invested and Lead Investor(s), 2018-2022
Table 8.3 Recent Initiatives: Information on Name of Companies, Location ofHeadquarters, Year of Initiative and Type of Initiative, 2018-2022
Table 9.1 Patent Analysis: CPC Symbols
Table 9.2 Patent Analysis: Most Popular CPC Symbols
Table 9.3 Patent Analysis: List of Top 10 CPC Symbols
Table 9.4 Patent Portfolio: Summary of Benchmarking Analysis
Table 9.5 Patent Analysis: Categorization Based on Weighted Valuation Score
Table 9.6 Patent Analysis: List of Relatively Higher Value Patents
Table 16.1 Tissue Engineering-based Skin Regeneration Products: Distribution by Type ofGraft 
Table 16.2 Tissue Engineering-based Skin Regeneration Products: Distribution by Area ofApplication
Table 16.3 Tissue Engineering-Based Skin Regeneration Products: Distribution by Type ofMaterial of Fabrication
Table 16.4 Tissue Engineering-based Skin Regeneration Products: Distribution by Launchyear
Table 16.5 Tissue Engineering-based Skin Regeneration Products Developers: Distribution by Year of Establishment
Table 16.6 Tissue Engineering-based Skin Regeneration Products Developers: Distribution by Company Size
Table 16.7 Tissue Engineering-based Skin Regeneration Products Developers: Distribution by Location of Headquarters
Table 16.8 Tissue Engineering-based Skin Regeneration Products Developers: Distribution by Target Market
Table 16.9 Tissue Engineering-based Bone Regeneration Products: Distribution by Type ofGraft 
Table 16.10 Tissue Engineering-based Bone Regeneration Products: Distribution by Formulation of Products
Table 16.11 Tissue Engineering-based Bone Regeneration Products: Distribution by Type ofMaterial of Scaffold
Table 16.12 Tissue Engineering-based Bone Regeneration Products: Distribution by Launchyear
Table 16.13 Tissue Engineering-based Bone Regeneration Products Developers: Distribution by Year of Establishment
Table 16.14 Tissue Engineering-based Bone Regeneration Products Developers: Distribution by Company Size
Table 16.15 Tissue Engineering-based Bone Regeneration Products Developers: Distribution by Location of Headquarters
Table 16.16 Tissue Engineering-based Bone Regeneration Products Developers: Distribution by Target Market
Table 16.17 Partnerships and Collaborations: Cumulative Year-wise Trend, 2017-2022
Table 16.18 Partnerships and Collaborations: Distribution by Type of Partnership
Table 16.19 Partnerships and Collaborations: Distribution by Year and Type of Partnership
Table 16.20 Partnerships and Collaborations: Distribution by Type of Partnership andCompany Size
Table 16.21 Most Active Players: Distribution by Number of Partnerships
Table 16.22 Partnerships and Collaborations: Local and International Agreements
Table 16.23 Partnerships and Collaborations: Distribution by Geography
Table 16.24 Partnerships and Collaborations: Intercontinental and Intracontinental Agreements
Table 16.25 Funding and Investment Analysis: Cumulative Year-wise Trend of Instances,2018-2022
Table 16.26 Funding and Investment Analysis: Cumulative Year-wise Trend of Amount
 Invested, 2018-2022 (USD Million)
Table 16.27 Funding and Investment Analysis: Distribution of Instances by Type of Funding
Table 16.28 Funding and Investment Analysis: Year-Wise Distribution of Instances by Typeof Funding, 2018-2022
Table 16.29 Funding and Investment Analysis: Year-Wise Distribution of Amount Invested byType of Funding, 2018-2022 (USD Million)
Table 16.30 Funding and Investment Analysis: Distribution by Type of Funding and Year ofEstablishment
Table 16.31 Funding and Investment Analysis: Distribution of Instances by Region
Table 16.32 Funding and Investment Analysis: Distribution of Total Amount Invested byRegion
Table 16.33 Most Active Players: Distribution by Number of Funding Instances
Table 16.34 Most Active Players: Distribution by Amount Raised (USD Million)
Table 16.35 Recent Initiatives Analysis: Cumulative Year-wise Trend of Instances, 2018-2022
Table 16.36 Recent Initiatives Analysis: Distribution by Type of Initiative
Table 16.37 Recent Initiatives Analysis: Distribution of Instances by Region
Table 16.38 Patent Analysis: Distribution by Type of Patent
Table 16.39 Patent Analysis: Cumulative Distribution by Publication Year, 2003-2022
Table 16.40 Patent Analysis: Cumulative Distribution of Granted Patents by Publication Year,2012-2022
Table 16.41 Patent Analysis: Cumulative Distribution of Filed Patents by Publication Year,2012-2022
Table 16.42 Patent Analysis: Cumulative Distribution of Patents by Publication Year and Typeof Player, 2012-2022
Table 16.43 Patent Analysis: Distribution by Issuing Authority
Table 16.44 Patent Analysis: Distribution by Patent Focus
Table 16.45 Patent Analysis: Distribution by Patent Age
Table 16.46 Patent Analysis: Distribution by CPC Symbols
Table 16.47 Leading Industry Players: Distribution by Number of Patents
Table 16.48 Leading Non-Industry Players: Distribution by Number of Patents
Table 16.49 Leading Inventors: Distribution by Number of Patents
Table 16.50 Patent Analysis (Top 10 CPC Symbols): Benchmarking by Leading Players
Table 16.51 Patent Analysis (Leading Players): Benchmarking by Top 10 CPC Symbols
Table 16.52 Patent Analysis: Valuation Analysis
Table 16.53 Grant Analysis: Cumulative Trend by Year of Grant Award, 2017- 2022
Table 16.54 Grant Analysis: Analysis of Amount Awarded by Year
Table 16.55 Grant Analysis: Distribution by Amount Awarded (USD Million), 2017-2022
Table 16.56 Grant Analysis: Distribution by Support Period
Table 16.57 Grant Analysis: Distribution by Funding Institute Center and Support
Table 16.58 Grant Analysis: Distribution by Type of Grant Application
Table 16.59 Grant Analysis: Distribution by Purpose of Grant Award
Table 16.60 Grant Analysis: Distribution by Activity Code
Table 16.61 Word Cloud: NIH spending Category
Table 16.62 Grant Analysis: Distribution by Study Section Involved
Table 16.63 Popular NIH Departments: Distribution by Number of Grants
Table 16.64 Grant Analysis: Distribution by Type of Recipient Organization
Table 16.65 Most Prominent Program Officers: Distribution by Number of Grants
Table 16.66 Popular Recipient Organization: Distribution by Number of Grants
Table 16.67 Popular Recipient Organization: Distribution Grant Amount
Table 16.68 Grant Analysis: Regional Distribution of Recipient Organization
Table 16.69 Grant Analysis: Leading Funding Institutes: Distribution by Number of Grants
Table 16.70 Tissue Engineering-based Skin Regeneration Products Market, Conservative, Baseand Optimistic Scenarios, 2022-2035 (USD Million)
Table 16.71 Tissue Engineering-based Skin Regeneration Products Market: Distribution byType of Graft, 2022 and 2035
Table 16.72 Tissue Engineering-based Skin Regeneration Products Market for Allografts,Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Million)
Table 16.73 Tissue Engineering-based Skin Regeneration Products Market for Autografts,Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Million)
Table 16.74 Tissue Engineering-based Skin Regeneration Products Market for Xenografts,Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Million)
Table 16.75 Tissue Engineering-based Skin Regeneration Products Market: Distribution byArea of Application, Conservative, Base and Optimistic Scenarios, 2022 and 2035 
Table 16.76 Tissue Engineering-based Skin Regeneration Products Market for Burn Healing,Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Million)
Table 16.77 Tissue Engineering-based Skin Regeneration Products Market for SurgicalHealing, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Million)
Table 16.78 Tissue Engineering-based Skin Regeneration Products Market for WoundHealing, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Million)
Table 16.79 Tissue Engineering-based Skin Regeneration Products Market for Others,Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Million)
Table 16.80 Tissue Engineering-based Skin Regeneration Products Market: Distribution byMaterial of Scaffold, Conservative, Base and Optimistic Scenarios, 2022 and 2035
Table 16.81 Tissue Engineering-based Skin Regeneration Products Market for CollagenTissues, Conservative, Base and Optimistic Scenarios, 2022-2035(USD Million)
Table 16.82 Tissue Engineering-based Skin Regeneration Products Market for HumanPlacental Tissues, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Million)
Table 16.83 Tissue Engineering-based Skin Regeneration Products Market for Other HumanTissues, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Million)
Table 16.84 Tissue Engineering-based Skin Regeneration Products Market for Other AnimalTissues, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Million)
Table 16.85 Tissue Engineering-based Skin Regeneration Products Market for Other Materialof Scaffold, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Million)
Table 16.86 Tissue Engineering-based Skin Regeneration Products Market: Analysis byEnd User 2022 and 2035
Table 16.87 Tissue Engineering-based Skin Regeneration Products Market for Ambulatory Surgical Centers, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Million)
Table 16.88 Tissue Engineering-based Skin Regeneration Products Market for Hospitals,Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Million)
Table 16.89 Tissue Engineering-based Skin Regeneration Products Market for SpecialtyClinics, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Million)
Table 16.90 Tissue Engineering-based Skin Regeneration Products Market: Distribution byGeography, 2022 and 2035 
Table 16.91 Tissue Engineering-based Skin Regeneration Products Market in North America,Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Million)
Table 16.92 Tissue Engineering-based Skin Regeneration Products Market in the US,Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Million)
Table 16.93 Tissue Engineering-based Skin Regeneration Products Market in Canada,Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Million)
Table 16.94 Tissue Engineering-based Skin Regeneration Products Market in Europe,Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Million)
Table 16.95 Tissue Engineering-based Skin Regeneration Products Market in France,Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Million)
Table 16.96 Tissue Engineering-based Skin Regeneration Products Market in Germany,Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Million)
Table 16.97 Tissue Engineering-based Skin Regeneration Products Market in Italy,Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Million)
Table 16.98 Tissue Engineering-based Skin Regeneration Products Market in the Netherlands,Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Million)
Table 16.99 Tissue Engineering-based Skin Regeneration Products Market in Spain,Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Million)
Table 16.100 Tissue Engineering-based Skin Regeneration Products Market in the UK,Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Million)
Table 16.101 Tissue Engineering-based Skin Regeneration Products Market in Asia,Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Million)
Table 16.102 Tissue Engineering-based Skin Regeneration Products Market in China,Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Million)
Table 16.103 Tissue Engineering-based Skin Regeneration Products Market in India,Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Million)
Table 16.104 Tissue Engineering-based Skin Regeneration Products Market in Japan, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Million)
Table 16.105 Tissue Engineering-based Skin Regeneration Products Market in South Korea,Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Million)
Table 16.106 Tissue Engineering-based Regeneration Products Market in Middle East and NorthAfrica, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Million)
Table 16.107 Tissue Engineering-based Skin Regeneration Products Market in Israel,Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Million)
Table 16.108 Tissue Engineering-based Skin Regeneration Products Market in Turkey,Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Million)
Table 16.109 Tissue Engineering-based Skin Regeneration Products Market in Latin America,Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Million)
Table 16.110 Tissue Engineering-based Skin Regeneration Products Market in Brazil,Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Million)
Table 16.111 Tissue Engineering-based Skin Regeneration Products Market in Rest of theWorld, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Million)
Table 16.112 Tissue Engineering-based Skin Regeneration Products Market in Australia,Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Million)
Table 16.113 Tissue Engineering-based Skin Regeneration Products Market in New Zealand,Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Million)
Table 16.114 Tissue Engineering-based Bone Regeneration Products Market, Conservative,Base and Optimistic Scenarios, 2022-2035, (USD Million)
Table 16.115 Tissue Engineering-based Bone Regeneration Products Market: Distribution by Type of Graft, 2022 and 2035
Table 16.116 Tissue Engineering-based Bone Regeneration Products Market for Allografts,Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Million)
Table 16.117 Tissue Engineering-based Bone Regeneration Products Market for Xenografts,Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Million)
Table 16.118 Tissue Engineering-based Bone Regeneration Products Market: Distribution by Material of Scaffold, 2022 and 2035
Table 16.119 Tissue Engineering-based Bone Regeneration Products Market for Bone Tissues,Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Million)
Table 16.120 Tissue Engineering-based Bone Regeneration Products Market for CollagenTissues, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Million)
Table 16.121 Tissue Engineering-based Bone Regeneration Products Market for Stem Cell,Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Million)
Table 16.122 Tissue Engineering-based Bone Regeneration Products Market for Other Materialsof Scaffold, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Million)
Table 16.123 Tissue Engineering-based Bone Regeneration Products Market: Distribution byEnd User 2022 and 2035
Table 16.124 Tissue Engineering-based Bone Regeneration Products Market for AmbulatorySurgical Centers, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Million)
Table 16.125 Tissue Engineering-based Bone Regeneration Products Market for Hospitals,Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Million)
Table 16.126 Tissue Engineering-based Bone Regeneration Products Market for SpecialtyClinics, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Million)
Table 16.127 Tissue Engineering-based Bone Regeneration Products Market: Distribution byGeography, 2022 and 2035 
Table 16.128 Tissue Engineering-based Bone Regeneration Products Market in NorthAmerica, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Million)
Table 16.129 Tissue Engineering-based Bone Regeneration Products Market in the US,Conservative, Base and Optimistic Scenarios, 2022-2035, (USD Million)
Table 16.130 Tissue Engineering-based Bone Regeneration Products Market in Canada,Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Million)
Table 16.131 Tissue Engineering-based Bone Regeneration Products Market in Europe,Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Million)
Table 16.132 Tissue Engineering-based Bone Regeneration Products Market in France,Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Million)
Table 16.133 Tissue Engineering-based Bone Regeneration Products Market in Germany,Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Million)
Table 16.134 Tissue Engineering-based Bone Regeneration Products Market in Italy,Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Million)
Table 16.135 Tissue Engineering-based Bone Regeneration Products Market in the Netherlands,Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Million)
Table 16.136 Tissue Engineering-based Bone Regeneration Products Market in Spain,Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Million)
Table 16.137 Tissue Engineering-based Bone Regeneration Products Market in the UK, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Million)
Table 16.138 Tissue Engineering-based Bone Regeneration Products Market in Asia,Conservative, Base and Optimistic Scenarios, 2022-2035 USD Million)
Table 16.139 Tissue Engineering-based Bone Regeneration Products Market in China,Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Million)
Table 16.140 Tissue Engineering-based Bone Regeneration Products Market in India,Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Million)
Table 16.141 Tissue Engineering-based Bone Regeneration Products Market in Japan,Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Million)
Table 16.142 Tissue Engineering-based Bone Regeneration Products Market in SouthKorea,2022-2035 (USD Million)
Table 16.143 Tissue Engineering-based Regeneration Products Market in Middle East and NorthAfrica, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Million)
Table 16.144 Tissue Engineering-based Bone Regeneration Products Market in Israel,Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Million)
Table 16.145 Tissue Engineering-based Bone Regeneration Products Market in Turkey,Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Million)
Table 16.146 Tissue Engineering-based Bone Regeneration Products Market in LatinAmerica,2022-2035 (USD Million)
Table 16.147 Tissue Engineering-based Bone Regeneration Products Market in Brazil,Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Million)
Table 16.148 Tissue Engineering-based Bone Regeneration Products Market in Rest of the World, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Million)
Table 16.149 Tissue Engineering-based Bone Regeneration Products Market in Australia,Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Million)
Table 16.150 Tissue Engineering-based Bone Regeneration Products Market in New Zealand,Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Million)

List Of Companies

The following companies and organizations have been mentioned in the report:

  1. 3M 
  2. Academy Medical
  3. ACell
  4. Additive Manufacturing
  5. Advanced Regenerative Manufacturing Institute
  6. Aedicell
  7. Allergan Aesthetics
  8. AlloSource
  9. American Military Medical Organization
  10. Amnio Technology
  11. Antares Pharma
  12. Applied Biologics
  13. Aroa Biosurgery
  14. Avista Healthcare
  15. Axis Spine Technologies
  16. Aziyo Biologics
  17. Baxter
  18. BD
  19. BioAesthetics
  20. Biodan
  21. BioHorizons Camlog
  22. BioRegenTech
  23. Biorez
  24. Biotech Dental
  25. Biotissue 
  26. Bioventus
  27. BONESUPPORT
  28. botiss biomaterials
  29. Brigham & Women’s Hospital
  30. Cartiva
  31. Children’s Medical Center
  32. CollPlant
  33. Crossroads
  34. DePuy Synthes
  35. Direct Biologics
  36. EnColl
  37. Exactech
  38. FIBRINET
  39. Fidia Farmaceutici 
  40. Flower Orthopeadics
  41. Geistlich Pharma
  42. Genesis Therapeutics
  43. Hans Biomed
  44. Harbor MedTech
  45. Human BioSciences
  46. Indiana University
  47. Innovative Cellular Therapeutics (ICT)
  48. Intalere
  49. Integra LifeSciences
  50. IntelliCell BioSciences
  51. Jagiellonian Center of Innovation
  52. Johns Hopkins University
  53. Kerecis
  54. L&C BIO
  55. Lifelink Systems
  56. LifeNet Health
  57. Marine Essence Biosciences 
  58. Massachusetts Institute of Technology
  59. MediWound
  60. MiMedx
  61. MIS Implants Technologies
  62. Misonix
  63. Molecular Biologicals
  64. Momentive 
  65. MTF Biologics
  66. Nano Orthopedics
  67. Net Health
  68. New York University Grossman School of Medicine
  69. Northwestern University 
  70. NuVasive
  71. Ohio State University
  72. OraPharma
  73. Organogenesis
  74. Orthocell
  75. Osiris Therapeutics
  76. Ozmedix
  77. Pandorum Technolog
  78. Paragon 28
  79. PerkinElmer 
  80. Premier
  81. Premier 
  82. ProgenaCare 
  83. PuraGraft
  84. Reprise Biomedical
  85. Rigenera HBW
  86. Rochal Industries
  87. Royal Biologics
  88. RTI Surgical
  89. Sanara MedTech
  90. Siemens Healthineers 
  91. Simplify Medical
  92. Skye Biologics
  93. Smart Matrix
  94. Smith+Nephew
  95. Stanford University
  96. StimLabs
  97. Straumann
  98. Stryker
  99. Swiss Life Sciences
  100. Synaptive Medical
  101. Synca
  102. Tepha 
  103. The Resource Group
  104. Tides Medical
  105. Tissue Regenix
  106. Triad Life Sciences
  107. Sichuan University
  108. University of Sydney
  109. University of California
  110. Drexel University
  111. Georgia State University
  112. University of Illinois 
  113. University of Leeds
  114. University of Michigan
  115. University of Pennsylvania
  116. University of Queensland
  117. University of Virginia
  118. University of Wuerzburg 
  119. VA Boston Healthcare System
  120. Veeva Systems
  121. Ventris Medical
  122. Vericel 
  123. Vilex
  124. VIVEX Biologics
  125. Wake Forest Institute for Regenerative Medicine
  126. Division of Public Health Sciences (Wake Forest University School of Medicine)
  127. Wipro
  128. Wright Medical
  129. Zimmer Biomet

PRICING DETAILS

USD 5,899

This license grants the right of use of the purchased report to a single recipient only (normally the person who buys the report). You may access the material on your computer, as and when required, for your own personal use. You may also print read more

This license grants the right of use of the purchased report by the employees of a business unit at a particular site/office location. The report may be accessed on the computer of any employee within the business unit. You may also print multiple read more

This license grants the right of use of the purchased report by a department / team of individuals (up to 8) n a particular organization. The license does not limit the use to a particular site / office location. The report may be accessed on the computer read more

This license entitles the buyer of the report to share, distribute the report (either full or in part) with other employees of the same firm/enterprise. The report may be accessed by any employee of the enterprise and there is no limit on the read more

Discounts available for multiple report purchases
sales@rootsanalysis.com